Iovance Biotherapeutics Inc (IOVA)

[MN Gopher]

Great Buyout read Badger. The business model was in “blast buyout” mode in the 4th Qtr in 2023.
Now we have FDA Approval & there is NO doubt the Mgmt team is building out Iovance & Amtagvi for a future buyout in 2025/2026 in my opinion.
In my opinion, we are waiting on future approvals like Amtagvi & Keytruda together & their nearly 67% effacy together
Looks like a frontline treatment in the making in late 2024, early 2025.
Once this occurs & our report out 5-31-24
On NSCLC will give us a peak into its potential for a Accelerated BLA in 2024/2025.
Wayne in my opinion will not take an offer under $100 a share combining stock options n cash.
Will see…
Stay Strong Longs, are future is so bright, we all gotta wear shades!

#Cure Cancer